Bradley M. Keegan
AeroLeads people directory · profile

Bradley M. Keegan Email & Phone Number

Ph.D., NIH Postdoctoral Research Scientist (NIDA) at The National Institute on Drug Abuse (NIDA)
Location: Baltimore, Maryland, United States 9 work roles 3 schools
2 work emails found @nd.edu 1 phone found area 608 LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 2 work emails · 1 phone

Work email b****@nd.edu
Direct phone (608) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
The National Institute on Drug Abuse (NIDA)
Role
Ph.D., NIH Postdoctoral Research Scientist (NIDA)
Location
Baltimore, Maryland, United States
Company size
320 employees

Who is Bradley M. Keegan? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Bradley M. Keegan is listed as Ph.D., NIH Postdoctoral Research Scientist (NIDA) at The National Institute on Drug Abuse (NIDA), a with 320 employees, based in Baltimore, Maryland, United States. AeroLeads shows a work email signal at nd.edu, phone signal with area code 608, and a matched LinkedIn profile for Bradley M. Keegan.

Bradley M. Keegan previously worked as IRTA Postdoctoral Research Fellow at The National Institute On Drug Abuse (Nida) and Institute for Precision Health - Berry Family Foundation Predoctoral Research Fellow at University Of Notre Dame. Bradley M. Keegan holds Ph.D. In Biochemistry (Medicinal Chemistry, Drug Discovery) from University Of Notre Dame.

Company email context

Email format at The National Institute on Drug Abuse (NIDA)

This section adds company-level context without repeating Bradley M. Keegan's masked contact details.

{first}.{last}@nd.edu
89% confidence

AeroLeads found 2 current-domain work email signals for Bradley M. Keegan. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Bradley M. Keegan

Bradley M. Keegan is a Ph.D., NIH Postdoctoral Research Scientist (NIDA) at The National Institute on Drug Abuse (NIDA). He possess expertise in research, microsoft word, powerpoint, microsoft office, microsoft excel and 10 more skills. He is proficient in Spanish.

Listed skills include Research, Microsoft Word, Powerpoint, Microsoft Office, and 11 others.

Current workplace

Bradley M. Keegan's current company

Company context helps verify the profile and gives searchers a useful next step.

The National Institute on Drug Abuse (NIDA)
The National Institute On Drug Abuse (Nida)
Ph.D., NIH Postdoctoral Research Scientist (NIDA)
rockville, maryland, united states
Website
drugabuse.gov
Employees
320
AeroLeads page
Company profile
View company profile Email format
9 roles

Bradley M. Keegan work experience

A career timeline built from the work history available for this profile.

Institute For Precision Health - Berry Family Foundation Predoctoral Research Fellow

University Of Notre Dame

South Bend, Indiana, United States

Aug 2021 - Nov 2022

Graduate Student Researcher

University Of Notre Dame

South Bend, Indiana

Primary Research Advisor: Brian S. J. Blagg, Ph.D.Projects:1) Design and synthesis of novel Aha1/Hsp90 inhibitors for the treatment of Alzheimer’s disease and other tauopathies.Publications/Manuscripts/Abstracts:An isoform-selective PTP1B inhibitor derived from nitrogen-atom augmentation of radicicol – T Shi, EMK Wijeratne, C Solano, AJ Ambrose, AB Ross, C Norwood, CK Orido, T Grigoryan, J Tillotson, M Kang, G Luo, BM Keegan, W Hu, BSJ Blagg, DD Zhang, AAL Gunatilaka, E Chapman (2019) (submitted to the Journal of the American Chemical Society)Disruptors of the Hsp90/Aha1 Complex that Reduce Tau Aggregation – BM Keegan, LB Shelton, JD Baker, LJ Blair, J Koren III, BSJ Blagg (2018) (Abstract) – The 9th International Conference of the Hsp90 Chaperone Machine – Leysin, Switzerland – presented October 18, 2018Design, Synthesis, and Evaluation of Disruptors of the Hsp90/Aha1 Complex for Reduction of Tau Aggregation – BM Keegan (2019) (Abstract) – CBBI Seminar – Notre Dame, IN, USA– presented February 28, 2019

Apr 2017 - Nov 2022

Cbbi Predoctoral Research Fellow

University Of Notre Dame

South Bend, Indiana

National Institutes of Health Ruth L. Kirschtein National Research Service Award, Chemistry-Biochemistry-Biology Interface (CBBI) Program, University of Notre Dame

Jul 2018 - Aug 2020

Co-Founder And Chief Science Officer

Encepheal Therapeutics, Inc.

Winston-Salem, Nc

Oversee the scientific development of all company assets, ensure quality and efficiency of outsourced preclinical/clinical work, and identify novel compounds and cutting edge technologies for potential incorporation into the business.

Jun 2015 - Jul 2017

Graduate Student Researcher

Wake Forest University

Primary Research Advisor: Allyn C. Howlett, Ph.D.Secondary Research Advisors: Rong Chen, Ph.D. and Brian A. McCool, Ph.D.Projects: 1) Shared receptor-signal transduction mechanisms of neurodegeneration in Alzheimer's/Parkinson's diseases and alcohol-/methamphetamine-induced neurotoxicity.2) Expression of inflammatory cytokines in individuals with early-onset to advanced-stage Alzheimer's disease upon intranasal insulin treatment; neuro-regeneration as a potential treatment for cognitive and neuromotor disorders.3) The effect of acute versus chronic methamphetamine on G-protein activation, phosphorylation of ERK 1/2, GSK3B, and DARPP-32, and function of D2 and CB1 receptors. Publications/Manuscripts/Abstracts:Chronic baclofen desensitizes GABAB-mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain – BM Keegan, TJR Beveridge, JJ Pezor, R Xiao, T Sexton, SR Childers, AC Howlett (2015) Neuropharmacology 95: 492-502 (ISSN 0028-3908).Cannabinoid Receptor Interacting Protein (CRIP) 1a competition with β-arrestin for CB1 receptor binding sites – LC Blume, T Patten, K Eldeeb, S Leone-Kabler, AA Ilyasov, BM Keegan, JE O’Neal, CE Bass, RR Hantgan, WT Lowther, DE Selley, AC Howlett (2016) Molecular Pharmacology 90(6); mol.116.104638 (DOI: http://dx.doi.org/10.1124/mol.116.104638)Chronic baclofen desensitizes GABAB- mediated G-protein activation and stimulates phosphorylation of kinases in mesocorticolimbic rat brain – BM Keegan, TJR Beveridge, JJ Pezor, R Xiao, T Sexton, SR Childers, AC Howlett (2014) (Abstract) Presented at Experimental Biology in April, 2014.

Jul 2013 - Dec 2015

Course Instructor, Mcat Exam Preparation Class

Wake Forest School Of Medicine

Taught an 8-week course on MCAT material (biology, chemistry, and physics), analytical reasoning, and test-taking strategy to students in premedical post-baccalaureate and Biomedical Sciences Masters programs under the supervision of Dr. A. Daniel Johnson.Spent 10+ hours per week designing lesson plans, giving class lectures, scoring practice exams, and privately tutoring students.

May 2014 - Sep 2014

Undergraduate Student Researcher

Wake Forest University

Research Advisor: Dr. Patricia C. Dos SantosProject: Characterization of the cysteine desulfurase CsdA from Escherichia coli

Jan 2012 - May 2013

Student Observer/Volunteer

Methodist Physicians Clinic

Council Bluffs, Ia

May 2011 - Aug 2011
Team & coworkers

Colleagues at The National Institute on Drug Abuse (NIDA)

Other employees you can reach at drugabuse.gov. View company contacts for 320 employees →

RT Richard Taylor Richard Taylor Colleague at The National Institute On Drug Abuse (Nida)Baltimore, Maryland, United States View → GM Gul Muhammad Khan Gul Muhammad Khan Colleague at The National Institute On Drug Abuse (Nida)Islamabad, Islāmābād, Pakistan View → LB Loretta Beuchert Loretta Beuchert Colleague at The National Institute On Drug Abuse (Nida)Rockville, Maryland, United States View → JL Juan L Gomez Juan L Gomez Colleague at The National Institute On Drug Abuse (Nida)Baltimore, Maryland, United States View → CB Clement Baba Clement Baba Colleague at The National Institute On Drug Abuse (Nida)Port Harcourt, Rivers State, Nigeria View → RP Rturp Program (Christie Brannock) Rturp Program (Christie Brannock) Colleague at The National Institute On Drug Abuse (Nida)Rosedale, Maryland, United States View → JC Jessica Cotto Jessica Cotto Colleague at The National Institute On Drug Abuse (Nida)Washington Dc-Baltimore Area, United States View → HB Heather Boerner Heather Boerner Colleague at The National Institute On Drug Abuse (Nida)Pittsburgh, Pennsylvania, United States View → MS Musa Sowe Musa Sowe Colleague at The National Institute On Drug Abuse (Nida)Banjul, The Gambia, Gambia View → WW William Wray William Wray Colleague at The National Institute On Drug Abuse (Nida)Frederick, Maryland, United States View →
3 education records

Bradley M. Keegan education

Ph.D. In Biochemistry (Medicinal Chemistry, Drug Discovery)

University Of Notre Dame

Berry Family Foundation Fellowship, Institute for Precision Health (2021 – present); CBBI Predoctoral Research Fellow, NIH (2018-2020).

M.Sc. In Biomedical Science, Thesis In Integrative Physiology And Pharmacology

Wake Forest School Of Medicine

Thesis: “Effects of baclofen and phenmetrazine on neuronal signaling pathways implicated in psychostimulant addiction” Research Area.

B.S. With Honors In Chemistry (Concentrations In Biochemistry And Premedicine), Minor In Biology

Wake Forest University

Honors Thesis: “Characterization of the cysteine desulfurase CsdA from Escherichia coli” Other Relevant Coursework: Drug Discovery.

FAQ

Frequently asked questions about Bradley M. Keegan

Quick answers generated from the profile data available on this page.

What company does Bradley M. Keegan work for?

Bradley M. Keegan works for The National Institute on Drug Abuse (NIDA).

What is Bradley M. Keegan's role at The National Institute on Drug Abuse (NIDA)?

Bradley M. Keegan is listed as Ph.D., NIH Postdoctoral Research Scientist (NIDA) at The National Institute on Drug Abuse (NIDA).

What is Bradley M. Keegan's email address?

AeroLeads has found 2 work email signals at @nd.edu for Bradley M. Keegan at The National Institute on Drug Abuse (NIDA).

What is Bradley M. Keegan's phone number?

AeroLeads has found 1 phone signal(s) with area code 608 for Bradley M. Keegan at The National Institute on Drug Abuse (NIDA).

Where is Bradley M. Keegan based?

Bradley M. Keegan is based in Baltimore, Maryland, United States while working with The National Institute on Drug Abuse (NIDA).

What companies has Bradley M. Keegan worked for?

Bradley M. Keegan has worked for The National Institute On Drug Abuse (Nida), University Of Notre Dame, Encepheal Therapeutics, Inc., Wake Forest University, and Wake Forest School Of Medicine.

Who are Bradley M. Keegan's colleagues at The National Institute on Drug Abuse (NIDA)?

Bradley M. Keegan's colleagues at The National Institute on Drug Abuse (NIDA) include Richard Taylor, Gul Muhammad Khan, Loretta Beuchert, Juan L Gomez, and Clement Baba.

How can I contact Bradley M. Keegan?

You can use AeroLeads to view verified contact signals for Bradley M. Keegan at The National Institute on Drug Abuse (NIDA), including work email, phone, and LinkedIn data when available.

What schools did Bradley M. Keegan attend?

Bradley M. Keegan holds Ph.D. In Biochemistry (Medicinal Chemistry, Drug Discovery) from University Of Notre Dame.

What skills is Bradley M. Keegan known for?

Bradley M. Keegan is listed with skills including Research, Microsoft Word, Powerpoint, Microsoft Office, Microsoft Excel, Biology, Teaching, and Spss.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.